GAMCO Investors’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
GAMCO Investors's AERI Position: Q4 2022 in Review
GAMCO Investors sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 45,050 shares — an estimated $682K sold.
GAMCO Investors first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $682K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- GAMCO Investors reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- GAMCO Investors sold 45,050 Aerie Pharmaceuticals shares in Q4 2022, an estimated $682K.
- GAMCO Investors first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
- GAMCO Investors's Aerie Pharmaceuticals position peaked at $682K in Q3 2022.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.